BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9294126)

  • 21. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.
    Veillard NR; Steffens S; Pelli G; Lu B; Kwak BR; Gerard C; Charo IF; Mach F
    Circulation; 2005 Aug; 112(6):870-8. PubMed ID: 16061736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
    Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
    Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
    Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
    Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
    J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
    Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
    Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.
    Pastore L; Belalcazar LM; Oka K; Cela R; Lee B; Chan L; Beaudet AL
    Gene; 2004 Mar; 327(2):153-60. PubMed ID: 14980712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice.
    Buono C; Pang H; Uchida Y; Libby P; Sharpe AH; Lichtman AH
    Circulation; 2004 Apr; 109(16):2009-15. PubMed ID: 15096453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of lysophospholipase 3 increases atherosclerosis in apolipoprotein E-deficient mice.
    Taniyama Y; Fuse H; Satomi T; Tozawa R; Yasuhara Y; Shimakawa K; Shibata S; Hattori M; Nakata M; Taketomi S
    Biochem Biophys Res Commun; 2005 Apr; 330(1):104-10. PubMed ID: 15781238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum.
    Palinski W; Ord VA; Plump AS; Breslow JL; Steinberg D; Witztum JL
    Arterioscler Thromb; 1994 Apr; 14(4):605-16. PubMed ID: 7511933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice.
    Cyrus T; Praticò D; Zhao L; Witztum JL; Rader DJ; Rokach J; FitzGerald GA; Funk CD
    Circulation; 2001 May; 103(18):2277-82. PubMed ID: 11342477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
    Véniant MM; Pierotti V; Newland D; Cham CM; Sanan DA; Walzem RL; Young SG
    J Clin Invest; 1997 Jul; 100(1):180-8. PubMed ID: 9202070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice.
    Reardon CA; Blachowicz L; White T; Cabana V; Wang Y; Lukens J; Bluestone J; Getz GS
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1011-6. PubMed ID: 11397712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice.
    Paulsson G; Zhou X; Törnquist E; Hansson GK
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):10-7. PubMed ID: 10634795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression.
    Roselaar SE; Kakkanathu PX; Daugherty A
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1013-8. PubMed ID: 8696940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice.
    Caligiuri G; Nicoletti A; Zhou X; Törnberg I; Hansson GK
    Atherosclerosis; 1999 Aug; 145(2):301-8. PubMed ID: 10488957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of neonatal tolerance to oxidized lipoprotein reduces atherosclerosis in ApoE knockout mice.
    Nicoletti A; Paulsson G; Caligiuri G; Zhou X; Hansson GK
    Mol Med; 2000 Apr; 6(4):283-90. PubMed ID: 10949909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis.
    George J; Afek A; Gilburd B; Levkovitz H; Shaish A; Goldberg I; Kopolovic Y; Wick G; Shoenfeld Y; Harats D
    Atherosclerosis; 1998 May; 138(1):147-52. PubMed ID: 9678780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse.
    Dansky HM; Charlton SA; Harper MM; Smith JD
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4642-6. PubMed ID: 9114044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short telomeres protect from diet-induced atherosclerosis in apolipoprotein E-null mice.
    Poch E; Carbonell P; Franco S; Díez-Juan A; Blasco MA; Andrés V
    FASEB J; 2004 Feb; 18(2):418-20. PubMed ID: 14688198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE-/- mice.
    Tang J; Kozaki K; Farr AG; Martin PJ; Lindahl P; Betsholtz C; Raines EW
    Am J Pathol; 2005 Sep; 167(3):901-12. PubMed ID: 16127167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.